TR199901307T2 - Oral skuam�z h�cre karsinomu i�in l�kotrien antagonistleri - Google Patents
Oral skuam�z h�cre karsinomu i�in l�kotrien antagonistleriInfo
- Publication number
- TR199901307T2 TR199901307T2 TR1999/01307T TR9901307T TR199901307T2 TR 199901307 T2 TR199901307 T2 TR 199901307T2 TR 1999/01307 T TR1999/01307 T TR 1999/01307T TR 9901307 T TR9901307 T TR 9901307T TR 199901307 T2 TR199901307 T2 TR 199901307T2
- Authority
- TR
- Turkey
- Prior art keywords
- lycotriene
- antagonists
- oral squamous
- cell carcinoma
- squamous cell
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3426996P | 1996-12-13 | 1996-12-13 | |
| US4087497P | 1997-03-21 | 1997-03-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199901307T2 true TR199901307T2 (xx) | 1999-08-23 |
Family
ID=26710754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1999/01307T TR199901307T2 (xx) | 1996-12-13 | 1997-12-02 | Oral skuam�z h�cre karsinomu i�in l�kotrien antagonistleri |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0964683A4 (de) |
| JP (1) | JP2001509142A (de) |
| KR (1) | KR20000069452A (de) |
| CN (1) | CN1245429A (de) |
| AU (1) | AU726215B2 (de) |
| CA (1) | CA2274855A1 (de) |
| EA (1) | EA002742B1 (de) |
| IL (1) | IL130304A0 (de) |
| NO (1) | NO992846L (de) |
| NZ (1) | NZ335922A (de) |
| PL (1) | PL334241A1 (de) |
| TR (1) | TR199901307T2 (de) |
| UA (1) | UA47505C2 (de) |
| WO (1) | WO1998025615A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002009700A1 (en) | 2000-07-28 | 2002-02-07 | Cancer Research Technology Limited | Cancer treatment by combination therapy |
| GB0121285D0 (en) | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| GB2386836B (en) | 2002-03-22 | 2006-07-26 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| GB2394658A (en) | 2002-11-01 | 2004-05-05 | Cancer Rec Tech Ltd | Oral anti-cancer composition |
| US8093253B2 (en) * | 2008-03-06 | 2012-01-10 | Hoffmann-La Roche Inc. | Leukotriene B4 inhibitors |
| KR101898879B1 (ko) | 2014-03-05 | 2018-09-14 | 재단법인 진안홍삼연구소 | 홍삼 가공 추출물을 유효성분으로 함유하는 구강편평세포암의 예방, 개선 또는 치료를 위한 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6372648A (ja) * | 1986-09-16 | 1988-04-02 | Sumitomo Pharmaceut Co Ltd | 新規不飽和脂肪酸誘導体 |
| PH30449A (en) * | 1991-11-25 | 1997-05-28 | Lilly Co Eli | Substituted phenyl phenol leukotriene antagonists |
| CZ276694A3 (en) * | 1991-11-25 | 1995-11-15 | Lilly Co Eli | Process for preparing diphenyl derivative |
-
1997
- 1997-02-12 UA UA99063226A patent/UA47505C2/uk unknown
- 1997-12-02 IL IL13030497A patent/IL130304A0/xx unknown
- 1997-12-02 PL PL97334241A patent/PL334241A1/xx unknown
- 1997-12-02 NZ NZ335922A patent/NZ335922A/xx unknown
- 1997-12-02 CA CA002274855A patent/CA2274855A1/en not_active Abandoned
- 1997-12-02 AU AU78451/98A patent/AU726215B2/en not_active Ceased
- 1997-12-02 CN CN97181730A patent/CN1245429A/zh active Pending
- 1997-12-02 EA EA199900543A patent/EA002742B1/ru not_active IP Right Cessation
- 1997-12-02 EP EP97949709A patent/EP0964683A4/de not_active Withdrawn
- 1997-12-02 WO PCT/US1997/021953 patent/WO1998025615A1/en not_active Ceased
- 1997-12-02 KR KR1019997005275A patent/KR20000069452A/ko not_active Ceased
- 1997-12-02 JP JP52676298A patent/JP2001509142A/ja not_active Ceased
- 1997-12-02 TR TR1999/01307T patent/TR199901307T2/xx unknown
-
1999
- 1999-06-11 NO NO992846A patent/NO992846L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL130304A0 (en) | 2000-06-01 |
| UA47505C2 (uk) | 2002-07-15 |
| NO992846D0 (no) | 1999-06-11 |
| KR20000069452A (ko) | 2000-11-25 |
| CN1245429A (zh) | 2000-02-23 |
| JP2001509142A (ja) | 2001-07-10 |
| NZ335922A (en) | 2000-12-22 |
| EA002742B1 (ru) | 2002-08-29 |
| WO1998025615A1 (en) | 1998-06-18 |
| AU7845198A (en) | 1998-07-03 |
| AU726215B2 (en) | 2000-11-02 |
| EA199900543A1 (ru) | 2000-02-28 |
| EP0964683A1 (de) | 1999-12-22 |
| EP0964683A4 (de) | 2002-08-14 |
| PL334241A1 (en) | 2000-02-14 |
| NO992846L (no) | 1999-06-11 |
| CA2274855A1 (en) | 1998-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200100167A (et) | 4-amino-asendatud 2-asendatud 1, 2, 3, 4-tetrahüdrokinoliinid kui CETP inhibiitorid | |
| BR9810342A (pt) | Novos compostos imidazola substituìdos | |
| DE69917296D1 (de) | Neue substituierte triazolverbindungen | |
| PT998460E (pt) | Novos derivados de tetrazole | |
| DK0928362T3 (da) | Blokerende sammensætning til anvendelse i en underjordisk formation | |
| NO20011429L (no) | Fremgangsmåte for å legge syntetisk gress | |
| TR200100189T2 (tr) | Hücre yapışması engelleyici iltihaplanmaya karşı bileşikler | |
| ATE224386T1 (de) | Neue in 6-position substituierte phenanthridine | |
| TR200000740T2 (tr) | Dişleri beyazlatmak için metod ve kompozisyonlar. | |
| ATE297898T1 (de) | 4-carboxamino-2-subsitutierte-1,2,3,4- tetrahydrochinoline als cetp inhibitoren | |
| EA200100732A1 (ru) | Противовоспалительные и иммуносупрессорные соединения, ингибирующие клеточную адгезию | |
| TR200002345T2 (tr) | Glukokortikoit seçiçi antienflamatuar ajanlar | |
| ATE510553T1 (de) | Beta-2-glycoprotein 1 als angiogenesehemmer | |
| MY129445A (en) | Compositions for treating inflammatory response | |
| EE200100039A (et) | Ftalasiinderivaadid kui fosfodiesteraas-4 inhibiitorid | |
| TR200102041T2 (tr) | Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar | |
| ATE245623T1 (de) | Verbindungen mit zytoprotektiver wirkung | |
| TR199901307T2 (xx) | Oral skuam�z h�cre karsinomu i�in l�kotrien antagonistleri | |
| EE200000733A (et) | Tetrahüdrokinoliini derivaadid kui glütsiini antagonistid | |
| AR026901A1 (es) | Peptidos con n-alquilacion que tienen actividad antiangiogenica | |
| EA200300468A1 (ru) | Подавление зависимости опухолевых клеток от фактора роста | |
| DE3873278D1 (de) | Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren. | |
| DE69923854D1 (de) | Rar-antagonisten zur verhütung für männer | |
| BR9902101B1 (pt) | grade de eletrodo para baterias de chumbo. | |
| AU2002224431A1 (en) | 2-substituted heterocyclic compounds and their use in treating multidrug resistance |